BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35732801)

  • 21. Next steps in Ewing sarcoma (epi-)genomics.
    Sannino G; Orth MF; Grünewald TG
    Future Oncol; 2017 Jun; 13(14):1207-1211. PubMed ID: 28589731
    [No Abstract]   [Full Text] [Related]  

  • 22. An inducible ectopic expression system of EWSR1-FLI1 as a tool for understanding Ewing sarcoma oncogenesis.
    García-Domínguez DJ; Hontecillas-Prieto L; León EA; Sánchez-Molina S; Rodríguez-Núñez P; Morón FJ; Hajji N; Mackintosh C; de Álava E
    PLoS One; 2020; 15(6):e0234243. PubMed ID: 32502203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of EWSR1 (Ewing sarcoma breakpoint region 1/EWS RNA binding protein 1) predicts poor survival in patients with hepatocellular carcinoma.
    Jiang W; Wu T; Shi X; Xu J
    Bioengineered; 2021 Dec; 12(1):7941-7949. PubMed ID: 34612781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenome mapping reveals distinct modes of gene regulation and widespread enhancer reprogramming by the oncogenic fusion protein EWS-FLI1.
    Tomazou EM; Sheffield NC; Schmidl C; Schuster M; Schönegger A; Datlinger P; Kubicek S; Bock C; Kovar H
    Cell Rep; 2015 Feb; 10(7):1082-95. PubMed ID: 25704812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EWSR1-FLI1 Activation of the Cancer/Testis Antigen FATE1 Promotes Ewing Sarcoma Survival.
    Gallegos ZR; Taus P; Gibbs ZA; McGlynn K; Gomez NC; Davis I; Whitehurst AW
    Mol Cell Biol; 2019 Jul; 39(14):. PubMed ID: 31036566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lurbinectedin Inactivates the Ewing Sarcoma Oncoprotein EWS-FLI1 by Redistributing It within the Nucleus.
    Harlow ML; Maloney N; Roland J; Guillen Navarro MJ; Easton MK; Kitchen-Goosen SM; Boguslawski EA; Madaj ZB; Johnson BK; Bowman MJ; D'Incalci M; Winn ME; Turner L; Hostetter G; Galmarini CM; Aviles PM; Grohar PJ
    Cancer Res; 2016 Nov; 76(22):6657-6668. PubMed ID: 27697767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple splice variants of EWSR1-ETS fusion transcripts co-existing in the Ewing sarcoma family of tumors.
    Patócs B; Németh K; Garami M; Arató G; Kovalszky I; Szendrői M; Fekete G
    Cell Oncol (Dordr); 2013 Jun; 36(3):191-200. PubMed ID: 23494411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncogenic ETS fusions deregulate E2F3 target genes in Ewing sarcoma and prostate cancer.
    Bilke S; Schwentner R; Yang F; Kauer M; Jug G; Walker RL; Davis S; Zhu YJ; Pineda M; Meltzer PS; Kovar H
    Genome Res; 2013 Nov; 23(11):1797-809. PubMed ID: 23940108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ewing sarcoma of the small bowel: a study of seven cases, including one with the uncommonly reported EWSR1-FEV translocation.
    Milione M; Gasparini P; Sozzi G; Mazzaferro V; Ferrari A; Casali PG; Perrone F; Tamborini E; Pellegrinelli A; Gherardi G; Arrigoni G; Collini P; Testi A; De Paoli E; Aiello A; Pilotti S; Pelosi G
    Histopathology; 2014 Jun; 64(7):1014-26. PubMed ID: 24898918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological and molecular spectrum of ewing sarcomas/PNETs, including validation of EWSR1 rearrangement by conventional and array FISH technique in certain cases.
    Rekhi B; Vogel U; Basak R; Desai SB; Jambhekar NA
    Pathol Oncol Res; 2014 Jul; 20(3):503-16. PubMed ID: 24293381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solid endobronchial tumor with EWSR1-FLI1 fusion gene - A diagnostically challenging case of the Ewing sarcoma.
    Kirishima M; Kato I; Hisaoka M; Nakatani Y; Takeda AH; Mizuno K; Tanimoto A
    Pathol Int; 2021 Jul; 71(7):488-490. PubMed ID: 34111315
    [No Abstract]   [Full Text] [Related]  

  • 32. Genotoxic stress inhibits Ewing sarcoma cell growth by modulating alternative pre-mRNA processing of the RNA helicase DHX9.
    Fidaleo M; Svetoni F; Volpe E; Miñana B; Caporossi D; Paronetto MP
    Oncotarget; 2015 Oct; 6(31):31740-57. PubMed ID: 26450900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combining PARP-1 inhibition and radiation in Ewing sarcoma results in lethal DNA damage.
    Lee HJ; Yoon C; Schmidt B; Park DJ; Zhang AY; Erkizan HV; Toretsky JA; Kirsch DG; Yoon SS
    Mol Cancer Ther; 2013 Nov; 12(11):2591-600. PubMed ID: 23966622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BET bromodomain inhibitors suppress EWS-FLI1-dependent transcription and the IGF1 autocrine mechanism in Ewing sarcoma.
    Loganathan SN; Tang N; Fleming JT; Ma Y; Guo Y; Borinstein SC; Chiang C; Wang J
    Oncotarget; 2016 Jul; 7(28):43504-43517. PubMed ID: 27259270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Linking germline and somatic variation in Ewing sarcoma.
    Gomez NC; Davis IJ
    Nat Genet; 2015 Sep; 47(9):964-5. PubMed ID: 26313223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. USP19 deubiquitinates EWS-FLI1 to regulate Ewing sarcoma growth.
    Gierisch ME; Pedot G; Walser F; Lopez-Garcia LA; Jaaks P; Niggli FK; Schäfer BW
    Sci Rep; 2019 Jan; 9(1):951. PubMed ID: 30700749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic EWSR1 Fusion Sequence as Highly Sensitive and Dynamic Plasma Tumor Marker in Ewing Sarcoma.
    Krumbholz M; Hellberg J; Steif B; Bäuerle T; Gillmann C; Fritscher T; Agaimy A; Frey B; Juengert J; Wardelmann E; Hartmann W; Juergens H; Dirksen U; Metzler M
    Clin Cancer Res; 2016 Sep; 22(17):4356-65. PubMed ID: 27283964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishment of multiplex RT-PCR to detect fusion genes for the diagnosis of Ewing sarcoma.
    Ueno-Yokohata H; Okita H; Nakasato K; Kiyotani C; Kato M; Matsumoto K; Kiyokawa N; Nakazawa A; Yoshioka T
    Diagn Pathol; 2021 Nov; 16(1):102. PubMed ID: 34749732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of FAS exon definition and apoptosis by the Ewing sarcoma protein.
    Paronetto MP; Bernardis I; Volpe E; Bechara E; Sebestyén E; Eyras E; Valcárcel J
    Cell Rep; 2014 May; 7(4):1211-26. PubMed ID: 24813895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Promoter-Associated Noncoding RNA
    Palombo R; Frisone P; Fidaleo M; Mercatelli N; Sette C; Paronetto MP
    Cancer Res; 2019 Jul; 79(14):3570-3582. PubMed ID: 31072811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.